Product image of Nhytida (Ethinylestradiol, Gestodene) supplied by GNH India

Nhytida

Active Ingredient:
Ethinylestradiol, Gestodene
Origin:
EU

Nhytida (Ethinylestradiol, Gestodene)

Ethinylestradiol, the active ingredient in Nhytida, is a combined oral contraceptive presented as an oral tablet for oral use. It works together with gestodene to prevent pregnancy in women of reproductive age by inhibiting ovulation and altering cervical mucus. The formulation combines ethinyloestradiol with gestodene, providing a low‑dose estrogen‑progestin regimen that aligns with European Union standards for safety and efficacy.

GNH India supplies Nhytida as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide, ensuring consistent quality and regulatory compliance across markets.

Manufacturer / TM Owner

Laboratorios León Farma, S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Nhytida, a combined oral contraceptive, acts on the hypothalamic‑pituitary‑ovarian axis to prevent pregnancy.
  • Prevention of pregnancy: provides reliable contraceptive protection by suppressing ovulation, thickening cervical mucus, and altering the endometrium when taken consistently as prescribed.
  • Management of menstrual disorders: can be used to treat dysmenorrhea and irregular menstrual cycles, helping to achieve more predictable bleeding patterns.
  • Acne reduction: the hormonal balance may improve acne in some women by decreasing androgenic activity.

How It Works

  • Nhytida combines ethinylestradiol, a synthetic estrogen, with gestodene, a progestogen. The estrogen component provides negative feedback to the hypothalamus and pituitary, reducing the mid‑cycle surge of luteinizing hormone (LH) and follicle‑stimulating hormone (FSH), thereby suppressing ovulation. Gestodene further stabilizes the endometrial lining and increases the viscosity of cervical mucus, creating an environment less favorable for sperm penetration and implantation.

Side Effects

Common Side Effects

  • Nausea: mild to moderate stomach upset, especially during the first cycles.
  • Breast tenderness: temporary swelling or discomfort of the breasts.
  • Headache: occasional mild to moderate headaches.
  • Spotting or breakthrough bleeding: irregular light bleeding between periods.
  • Mood changes: fluctuations in mood or mild irritability.
  • Weight gain: slight increase in body weight due to fluid retention.

Serious or Rare Side Effects

  • Venous thromboembolism: blood clots in deep veins, potentially leading to pulmonary embolism.
  • Arterial thrombosis: risk of heart attack or stroke, especially in smokers over 35.
  • Hypertension: significant increase in blood pressure.
  • Liver tumor: rare benign hepatic adenoma.
  • Gallbladder disease: inflammation or stones in the gallbladder.

Precautions & Warnings

Before prescribing Nhytida, consider the following precautions:

  • Contraindicated in pregnancy: product is classified as Category X and must not be used.
  • Avoid in smokers over 35: increased risk of cardiovascular events.
  • Assess history of thromboembolic disorders: risk of clot formation may be elevated.
  • Monitor blood pressure regularly: the formulation can cause hypertension.
  • Evaluate liver function: hepatic disease may affect drug metabolism.
  • Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Nhytida may interact with several medications.

Major Interactions (Avoid)

  • Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin): may reduce contraceptive efficacy.
  • Rifampin or rifabutin: can lower plasma levels of ethinylestradiol and gestodene.
  • Certain antiretrovirals (e.g., efavirenz): may diminish hormonal protection.

Moderate Interactions (Monitor Closely)

  • Broad‑spectrum antibiotics (e.g., ampicillin): may slightly decrease effectiveness.
  • St. John’s wort: herbal inducer that can lower hormone concentrations.
  • Diuretics: may increase the risk of hypertension when combined with the contraceptive.

Frequently Asked Questions

Nhytida is a combined oral contraceptive indicated primarily for the prevention of pregnancy in women of reproductive age. It works by suppressing ovulation and altering cervical mucus, providing reliable birth control when taken as prescribed.

Ethinylestradiol, the estrogen component, provides negative feedback to the hypothalamus and pituitary gland, reducing the mid‑cycle surge of luteinizing hormone (LH) and follicle‑stimulating hormone (FSH). This suppression prevents ovulation and, together with gestodene, creates an environment unfavorable for fertilization and implantation.

The dosing regimen for Nhytida is determined by the prescribing healthcare professional. Typically, it is taken as a daily oral tablet following the specific cycle schedule indicated on the prescription label, without deviation unless directed by a clinician.

Nhytida is classified as Pregnancy Category X, meaning it must not be used during pregnancy because it can cause fetal harm. It is also not recommended while breastfeeding, as hormonal exposure may affect milk production and infant health.

To order Nhytida, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and necessary import documentation.

Nhytida contains ethinylestradiol and gestodene, a low‑dose estrogen‑progestin combination that offers effective contraception with a favorable bleeding profile. Compared with older formulations that use higher estrogen doses, Nhytida may present a lower risk of estrogen‑related side effects while maintaining comparable contraceptive efficacy.

Nhytida tablets should be stored at ambient temperature below 25 °C, in their original packaging, and protected from moisture and direct sunlight. This ensures the stability of the active ingredients throughout the product’s shelf life.

Nhytida is taken orally as a tablet, usually once daily at the same time each day. The typical regimen follows a 21‑day active tablet sequence followed by a 7‑day placebo or hormone‑free interval, but patients should follow the specific instructions provided by their prescriber.

The most serious risks include venous thromboembolism, arterial thrombosis (such as heart attack or stroke), hypertension, and rare liver tumors. Women with a history of clotting disorders, smoking over age 35, or certain cardiovascular conditions should be evaluated carefully before use.

Nhytida should not be used by women who are pregnant, have known or suspected breast cancer, have a history of thromboembolic disease, uncontrolled hypertension, severe liver disease, or are smokers aged 35 years or older. Contraindications are outlined in the product’s prescribing information.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ethinylestradiol, Gestodene

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT